Skip to Main Content

Repeat Dosing of Psilocybin in Migraine Headache

Conditions

Headaches

Phase I

What is the purpose of this trial?

In seeking to understand the capacity for psilocybin to reduce migraine headache burden, this study will investigate single and repeated dosing of psilocybin up to two doses. In seeking to identify an underlying mechanism in psilocybin's effects, neuroinflammatory markers for migraine headache will be measured.

  • Trial with
    Wallace Research Foundation
  • Start Date
    01/01/2021
  • End Date
    07/15/2022

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    04/05/2022
  • Study HIC
    #2000026974